Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo

NCT00258310 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: capecitabine
PROCEDURE: Surgery, chemotherapy and/or radiotherapy

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]